BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
116 hedge funds and large institutions have $639M invested in BioDelivery Sciences International, Inc. in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
59% more capital invested
Capital invested by funds: $403M → $639M (+$236M)
46% more call options, than puts
Call options by funds: $4.83M | Put options by funds: $3.31M
33% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 33
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
4% more funds holding
Funds holding: 112 → 116 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$35M |
| 2 |
State Street
Boston,
Massachusetts
|
+$21.4M |
| 3 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
+$10.9M |
| 4 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
+$7.84M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$7.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$19.4M |
| 2 |
DM
Deerfield Management
New York
|
-$16M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.3M |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.72M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.59M |
BDSI Hedge Fund Activity: Q3 2014 in Review
116 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2014, worth a combined $639M — up 59% from $403M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new BDSI positions and 20 closed out — a net gain of 4 holders — while 44 added to existing stakes and 33 trimmed.
The largest buyer was Invesco, adding an estimated $35M. The largest seller was Broadfin Capital, cutting an estimated $19.4M.
- 116 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2014, up from 112 in Q2 2014.
- Funds reported $639M of BioDelivery Sciences International, Inc. stock for Q3 2014, up 59% quarter-over-quarter.
- 24 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2014 and 20 closed out, a net change of +4 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2014 was Invesco, an estimated $35M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $19.4M sold.
Based on aggregated 13F filings for Q3 2014.